Research progress on the role of the Wnt signaling pathway in pituitary adenoma.
PA
TME
Wnt pathway inhibitors
Wnt signaling pathway
non-coding RNA
targeted drugs
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
05
2023
accepted:
28
08
2023
medline:
31
10
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
epublish
Résumé
Pituitary adenoma (PA) is the third most common central nervous system tumor originating from the anterior pituitary, but its pathogenesis remains unclear. The Wnt signaling pathway is a conserved pathway involved in cell proliferation, Self-renewal of stem cells, and cell differentiation. It is related to the occurrence of various tumors, including PA. This article reviews the latest developments in Wnt pathway inhibitors and pathway-targeted drugs. It discusses the possibility of combining Wnt pathway inhibitors with immunotherapy to provide a theoretical basis for the combined treatment of PA.
Identifiants
pubmed: 37780610
doi: 10.3389/fendo.2023.1216817
pmc: PMC10538627
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1216817Informations de copyright
Copyright © 2023 Wang, Ma, Zhao, Liu, Ye and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Can J Neurol Sci. 2016 Mar;43(2):291-7
pubmed: 26522017
Int J Biol Sci. 2018 Apr 26;14(6):616-621
pubmed: 29904276
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6391-6402
pubmed: 31162548
Biomolecules. 2023 Mar 06;13(3):
pubmed: 36979418
Blood. 2020 Aug 6;136(6):674-683
pubmed: 32285126
Onkologie. 2013;36(7-8):444-9
pubmed: 23921765
Front Biosci. 2004 Jan 01;9:967-74
pubmed: 14766423
Biosci Biotechnol Biochem. 2019 Jun;83(6):1035-1044
pubmed: 30973065
J Clin Invest. 2003 Dec;112(11):1603-18
pubmed: 14660734
Front Oncol. 2023 Mar 10;13:1121787
pubmed: 36969011
Annu Rev Pathol. 2009;4:97-126
pubmed: 19400692
Cell Death Dis. 2020 Dec 14;11(12):1065
pubmed: 33311442
Oncol Lett. 2019 Jul;18(1):81-86
pubmed: 31289475
Sci Rep. 2014 Mar 27;4:4493
pubmed: 24670389
Ther Adv Musculoskelet Dis. 2013 Feb;5(1):13-31
pubmed: 23514963
Int J Cancer. 2013 Aug 1;133(3):556-67
pubmed: 23354914
J Asian Nat Prod Res. 2017 May;19(5):423-435
pubmed: 27588605
Pituitary. 2023 Jun;26(3):263-265
pubmed: 36870010
Eur J Endocrinol. 2018 Apr;178(4):353-364
pubmed: 29374071
J Clin Invest. 1990 Jul;86(1):336-40
pubmed: 1973174
Oncol Lett. 2016 Jul;12(1):199-206
pubmed: 27347125
J Neurooncol. 2022 Sep;159(3):665-674
pubmed: 35932358
J Cancer. 2021 Feb 5;12(7):2083-2091
pubmed: 33754007
Circulation. 2017 Sep 12;136(11):1022-1036
pubmed: 28674110
J Headache Pain. 2009 Feb;10(1):15-20
pubmed: 19067118
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):48-54
pubmed: 20211224
Mol Med Rep. 2017 Nov;16(5):5908-5914
pubmed: 28849207
Semin Cell Dev Biol. 2022 May;125:3-10
pubmed: 34686423
Endocrine. 2022 Sep;77(3):500-509
pubmed: 35711030
Med Sci Monit. 2019 Oct 12;25:7652-7659
pubmed: 31604907
Tumour Biol. 2022;44(1):85-105
pubmed: 35811548
Mol Med Rep. 2019 Oct;20(4):3276-3284
pubmed: 31432167
Curr Top Dev Biol. 2022;149:59-89
pubmed: 35606062
Cell Calcium. 2005 Sep-Oct;38(3-4):439-46
pubmed: 16099039
Front Endocrinol (Lausanne). 2021 May 24;12:667480
pubmed: 34108937
Semin Oncol. 2003 Oct;30(5 Suppl 16):14-20
pubmed: 14613022
Sci Signal. 2012 May 15;5(224):pe22
pubmed: 22589387
Lancet Haematol. 2020 Oct;7(10):e724-e736
pubmed: 32896301
Brain Res Bull. 2020 Aug;161:65-77
pubmed: 32389802
Neural Regen Res. 2012 Feb 5;7(4):283-9
pubmed: 25806070
Cell Tissue Res. 2016 May;364(2):309-18
pubmed: 26646542
Cancer Res. 2005 Nov 15;65(22):10214-22
pubmed: 16288009
Tumour Biol. 2014 Jun;35(6):5121-7
pubmed: 24643679
Endocr Rev. 2023 Mar 4;44(2):297-311
pubmed: 36269838
Int J Cancer. 2009 Jan 15;124(2):287-97
pubmed: 19003969
Molecules. 2023 Feb 20;28(4):
pubmed: 36838978
Pituitary. 2022 Oct;25(5):722-725
pubmed: 35670988
Cells. 2021 Dec 10;10(12):
pubmed: 34944004
J Clin Neurosci. 2013 May;20(5):721-5
pubmed: 23523357
Cell Death Dis. 2019 Jun 24;10(7):499
pubmed: 31235696
Front Neuroendocrinol. 2020 Jul;58:100852
pubmed: 32553750
Am J Cancer Res. 2019 Feb 01;9(2):330-346
pubmed: 30906632
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13636-41
pubmed: 9391078
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2859-63
pubmed: 9096311
Clin Cancer Res. 2006 Jan 15;12(2):383-91
pubmed: 16428476
Front Endocrinol (Lausanne). 2022 Jul 19;13:870172
pubmed: 35928898
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
Cancers (Basel). 2019 Nov 27;11(12):
pubmed: 31783579
J Neurosci. 2008 Jul 30;28(31):7900-10
pubmed: 18667622
Int J Biol Sci. 2022 Feb 28;18(5):2032-2046
pubmed: 35342346
Int J Mol Sci. 2022 Jul 12;23(14):
pubmed: 35887024
World Neurosurg. 2018 Nov;119:e23-e31
pubmed: 29966778
ScientificWorldJournal. 2007 Feb 02;7:161-76
pubmed: 17334608
Endocr Pathol. 2012 Jun;23(2):123-31
pubmed: 22327960
Oncol Lett. 2017 Mar;13(3):1587-1594
pubmed: 28454295
Mol Cell Endocrinol. 2018 Oct 15;474:168-175
pubmed: 29555596
J Clin Invest. 2020 Nov 2;130(11):6187
pubmed: 33044225
Neuro Oncol. 2022 Jun 1;24(6):964-973
pubmed: 34647594
Int J Oncol. 2018 Jun;52(6):1934-1946
pubmed: 29620167
Indian J Dermatol Venereol Leprol. 2023 Jan-Frebuary;89(1):160
pubmed: 36332091
Mol Med Rep. 2017 Apr;15(4):1793-1799
pubmed: 28260015
J Cell Sci. 2011 Feb 15;124(Pt 4):540-7
pubmed: 21245194
Osteoporos Int. 2018 Jan;29(1):211-221
pubmed: 28980049
Int J Oncol. 2015 Apr;46(4):1643-50
pubmed: 25646597
Int J Mol Sci. 2020 Jul 09;21(14):
pubmed: 32659938
Horm Metab Res. 2020 Jan;52(1):8-24
pubmed: 31863423
Endocrinology. 2011 Oct;152(10):3884-92
pubmed: 21810944
J Clin Neurosci. 2014 Jan;21(1):137-41
pubmed: 24200887
Dev Cell. 2003 Sep;5(3):367-77
pubmed: 12967557
Cancer Metastasis Rev. 2017 Mar;36(1):23-33
pubmed: 28197745
Front Immunol. 2023 Jan 26;14:1095943
pubmed: 36776869
Cancer Lett. 2002 Sep 8;183(1):95-101
pubmed: 12049819
Pituitary. 2015 Jun;18(3):335-42
pubmed: 24917361
J Neurooncol. 2014 Feb;116(3):523-31
pubmed: 24407733
Am J Ther. 2019 Jan/Feb;26(1):e122-e123
pubmed: 30601772
J Cell Biol. 2003 Sep 1;162(5):899-908
pubmed: 12952940
Biomed Pharmacother. 2019 Feb;110:473-481
pubmed: 30530050
Signal Transduct Target Ther. 2022 Jan 3;7(1):3
pubmed: 34980884
Science. 2003 Jun 6;300(5625):1529-30
pubmed: 12791979
J Neurooncol. 2014 May;117(3):379-94
pubmed: 24481996
Eur J Pharmacol. 2015 Sep 15;763(Pt A):122-30
pubmed: 25987418
J Transl Med. 2019 May 20;17(1):164
pubmed: 31109334
J Biol Chem. 2002 Sep 20;277(38):34727-35
pubmed: 12121999